Catherine Anne Foss

Title: Innovations and Contributions of Catherine Anne Foss

Introduction

Catherine Anne Foss is a prominent inventor based in Baltimore, MD (US). She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies and collagen mimetic peptides. With a total of 9 patents to her name, her work has the potential to impact cancer imaging and therapy.

Latest Patents

One of her latest patents involves the development of new monoclonal antibodies that recognize human prostate-specific membrane antigen (PSMA). This invention provides compositions and methods comprising isolated antibodies that can be utilized for imaging and therapy of PSMA-expressing cancers, such as prostate cancer. Another notable patent focuses on collagen mimetic peptides for targeting collagen strands for both in vitro and in vivo imaging and therapeutic use. This invention includes a caged collagen mimetic peptide (CCMP) that can bind collagen and denatured collagen, making it useful for research, diagnostic imaging, and therapeutic applications.

Career Highlights

Catherine has worked with esteemed institutions such as The Johns Hopkins University and the Institute of Biotechnology Cas, V.v.i. Her innovative research has positioned her as a leader in her field, contributing to advancements in medical technology.

Collaborations

Throughout her career, Catherine has collaborated with notable professionals, including Martin Gilbert Pomper and Ronnie Charles Mease. These partnerships have further enhanced her research and development efforts.

Conclusion

Catherine Anne Foss is a trailblazer in the field of biotechnology, with her patents paving the way for advancements in cancer treatment and imaging. Her contributions continue to influence the scientific community and improve patient outcomes.